| A genome-wide association study of acenocoumarol maintenance dosage M Teichert, M Eijgelsheim, F Rivadeneira, AG Uitterlinden, ... Human molecular genetics 18 (19), 3758-3768, 2009 | 181 | 2009 |
| A genome‐wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium W Tang, M Teichert, DI Chasman, JA Heit, PE Morange, G Li, N Pankratz, ... Genetic epidemiology 37 (5), 512-521, 2013 | 133 | 2013 |
| Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients S Ottenbros, M Teichert, R de Groot, F Griens, F Sodihardjo, M Wensing, ... International journal of clinical pharmacy 36, 336-344, 2014 | 79 | 2014 |
| Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands S Hanemaaijer, F Sodihardjo, A Horikx, M Wensing, PAGM De Smet, ... International journal of clinical pharmacy 37, 1128-1135, 2015 | 62 | 2015 |
| Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies M Teichert, T Schoenmakers, N Kylstra, B Mosk, ML Bouvy, ... International journal of clinical pharmacy 38, 870-879, 2016 | 61 | 2016 |
| SERIES: eHealth in primary care. Part 2: exploring the ethical implications of its application in primary care practice SN Boers, KR Jongsma, F Lucivero, J Aardoom, FL Büchner, M de Vries, ... European Journal of General Practice 26 (1), 26-32, 2020 | 58 | 2020 |
| Impact of polypharmacy and P-glycoprotein-and CYP3A4-modulating drugs on safety and efficacy of oral anticoagulation therapy in patients with atrial fibrillation RE Harskamp, M Teichert, WAM Lucassen, HCPM van Weert, RD Lopes Cardiovascular drugs and therapy 33, 615-623, 2019 | 58 | 2019 |
| Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment M Teichert, C Van Noord, AG Uitterlinden, A Hofman, PN Buhre, ... British journal of haematology 153 (3), 379-385, 2011 | 57 | 2011 |
| Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes M Teichert, M Eijgelsheim, AG Uitterlinden, PN Buhre, A Hofman, ... Pharmacogenetics and genomics 21 (1), 26-34, 2011 | 54 | 2011 |
| Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study M Teichert, LE Visser, RHN Van Schaik, A Hofman, AG Uitterlinden, ... Arteriosclerosis, thrombosis, and vascular biology 28 (4), 771-776, 2008 | 51 | 2008 |
| Long-term exposure to anticholinergic and sedative medications and cognitive and physical function in later life H Wouters, SN Hilmer, D Gnjidic, JP Van Campen, M Teichert, ... The Journals of Gerontology: Series A 75 (2), 357-365, 2020 | 48 | 2020 |
| Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period M Teichert, RHN Van Schaik, A Hofman, AG Uitterlinden, P de Smet, ... Clinical Pharmacology & Therapeutics 85 (4), 379-386, 2009 | 45 | 2009 |
| Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: a surveillance study GD Zielinski, N van Rein, M Teichert, FA Klok, FR Rosendaal, ... Research and Practice in Thrombosis and Haemostasis 4 (1), 141-153, 2020 | 38 | 2020 |
| Female sex as a risk modifier for stroke risk in atrial fibrillation: using CHA2DS2-VASc versus CHA2DS2-VA for stroke risk stratification in atrial fibrillation: a note of caution PB Nielsen, TF Overvad Thrombosis and haemostasis 120 (06), 894-898, 2020 | 36 | 2020 |
| Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data M Teichert, LE Visser, M Dufour, E Rodenburg, SMJM Straus, PAGM Smet, ... Drug safety 33, 315-326, 2010 | 36 | 2010 |
| Long‐term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users TI Verhoef, WK Redekop, MM Buikema, T Schalekamp, ... Journal of thrombosis and haemostasis 10 (4), 606-614, 2012 | 35 | 2012 |
| Sex differences associated with adverse drug reactions resulting in hospital admissions LC Hendriksen, PD van der Linden, ALM Lagro-Janssen, P van den Bemt, ... Biology of sex differences 12 (1), 34, 2021 | 34 | 2021 |
| Genetics in thrombophilia PH Reitsma Hämostaseologie 35 (01), 47-51, 2015 | 34 | 2015 |
| Discontinuation of β-blockers and the risk of myocardial infarction in the elderly M Teichert, PAGM De Smet, A Hofman, JCM Witteman, BHC Stricker Drug safety 30, 541-549, 2007 | 33 | 2007 |
| Self-management research of asthma and good drug use (SMARAGD study): a pilot trial E Kuipers, M Wensing, P de Smet, M Teichert International Journal of Clinical Pharmacy 39, 888-896, 2017 | 27 | 2017 |
